The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy

Docosahexaenoic acid (DHA), an omega-3 C22 natural fatty acid serving as a precursor for metabolic and biochemical pathways, was reported as a targeting ligand of anticancer drugs. However, its tumor targeting ability and mechanism has not been claimed. Here we hypothesized that the uptake of DHA by...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Siwen, Qin, Jingyi, Tian, Caiping, Cao, Jie, Fida, Guissi, Wang, Zhaohui, Chen, Haiyan, Qian, Zhiyu, Chen, Wei R, Gu, Yueqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116508/
https://www.ncbi.nlm.nih.gov/pubmed/25004114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116508/
https://www.ncbi.nlm.nih.gov/pubmed/25004114

Ejemplares similares